Arcutis sees explosive growth as ZORYVE captures ~41% of non-steroidal psoriasis scripts, with improving margins. See why ...

FOMC opted to leave its target range unchanged at 4.25%–4.50%, fresh details from the July meeting shed light on why ...

PACCAR is downgraded to a 'sell' as weakening truck demand, economic headwinds, and pricey valuations raise concerns for near ...

Victoria’s Secret faces brand challenges, store closures, and consumer uncertainty ahead of Q2 results. Read here for more on ...

BHK CEF trades at a discount with a 9.3% dividend yield. Explore its investment potential while weighing risks like dividend ...

The US dollar is getting sold off aggressively as the market interpreted dovish signs for a cut in September, even in a ...

Two small issuers and one SPAC priced offerings this past week, but there was big news in the pipeline, as a few large names ...

BBVA Argentina's Q2 2025 earnings dip 62% YoY amid inflation and market challenges. Despite strong loan growth, macro risks ...

F.N.B. Corporation's strong fundamentals, solid deposits, and robust credit quality back its stability. Read here for an ...

John Hancock Investment Management reports Q2 gains in its 2055 Lifetime Blend Portfolio. Learn how steady allocation and ...

Wall Street ended higher on Friday with the Dow closing at a record high after investors welcomed Federal Reserve Chair ...

Jerome Powell just concluded his much-anticipated speech at the Jackson Hole economic conference, and the reactions are ...